Conecte-se

Bibliografias temáticas / Pathogenic / Artigos de revistas

Artigos de revistas sobre o tema "Pathogenic"

Siga este link para ver outros tipos de publicações sobre o tema: Pathogenic.

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 11 de março de 2023

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Pathogenic".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

Gvozdyak, R. I. "«Pathogen-1» Experiment Aggression of pathogenic bacteria in microgravity". Kosmìčna nauka ì tehnologìâ 6, n.º 4 (30 de julho de 2000): 111. http://dx.doi.org/10.15407/knit2000.04.119.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Ruchel, Reinhard. "Proteinasen pathogener Pilze: Proteinases of pathogenic fungi". Mycoses 42, S1 (abril de 1999): 48–52. http://dx.doi.org/10.1111/j.1439-0507.1999.tb04527.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Gharwalova, Lucia, Marketa Kulisova, Anastasiia Vasyliuk, Helena Maresova, Andrea Palyzova, Linda Nedbalova e Irena Kolouchova. "Sphingolipids of plant pathogenic fungi". Plant Protection Science 57, No. 2 (1 de março de 2021): 134–39. http://dx.doi.org/10.17221/131/2020-pps.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Resumo:

Glycosphingolipids in filamentous fungi are significant components of the plasma membrane and are vital for different cellular processes, such as growth, morphological transition or signal transduction. Fungal growth inhibitors targeting glycosylinositolphosphoceramide (GIPCs) biosynthesis or antifungal compounds binding to GIPCs present in membranes could present a safe way of preventing fungal growth on crops since GIPCs are not present in mammalian cells. Mass spectrometry-based shotgun lipidomics was used to analyze sphingolipids of 11 fungal strains isolated from plant material. Molecular species with inositol ceramides containing zero to five carbohydrates were identified. Differences in the amount of individual molecular species were influenced by the taxonomic affiliation. All tested strains exhibited a relatively high content (more than 40 mol.%) of GIPCs with three and more saccharides attached to the polar head. It could be assumed that the sphingolipid profiles of the tested plant pathogens would be an adaptation mechanism to antifungal plant defensins.

4

Finn, Albert F., e Peter D. Gorevic. "Pathogenic paraproteins". Current Opinion in Rheumatology 2, n.º 4 (agosto de 1990): 652–60. http://dx.doi.org/10.1097/00002281-199002040-00017.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Horvat, Rebecca T. "PATHOGENIC FUNGI". Shock 30, n.º 6 (dezembro de 2008): 753. http://dx.doi.org/10.1097/01.shk.0000336210.36795.86.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Gould, EA, e T. Solomon. "Pathogenic flaviviruses". Lancet 371, n.º 9611 (fevereiro de 2008): 500–509. http://dx.doi.org/10.1016/s0140-6736(08)60238-x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

DIPERRI, G. "PATHOGENIC ENTAMOEBA". Lancet 331, n.º 8595 (maio de 1988): 1166. http://dx.doi.org/10.1016/s0140-6736(88)91980-0.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Gao, Shou-Jiang. "Pathogenic procedures". Trends in Microbiology 5, n.º 3 (março de 1997): 125–26. http://dx.doi.org/10.1016/s0966-842x(97)87506-3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Tran Van Nhieu, Guy. "Pathogenic paradox?" Trends in Microbiology 7, n.º 3 (março de 1999): 102. http://dx.doi.org/10.1016/s0966-842x(99)01473-0.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Casci, Tanita. "Pathogenic conversions". Nature Reviews Genetics 13, n.º 1 (16 de dezembro de 2011): 2. http://dx.doi.org/10.1038/nrg3143.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Dempsey, Laurie A. "Pathogenic antibodies". Nature Immunology 20, n.º 11 (22 de outubro de 2019): 1414. http://dx.doi.org/10.1038/s41590-019-0535-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

POOLMAN, J. "Pathogenic neisseriae". Lancet 336, n.º 8722 (outubro de 1990): 1061. http://dx.doi.org/10.1016/0140-6736(90)92518-m.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Prasanna, Arun N., e Sarika Mehra. "Comparative Phylogenomics of Pathogenic and Non-Pathogenic Mycobacterium". PLoS ONE 8, n.º 8 (28 de agosto de 2013): e71248. http://dx.doi.org/10.1371/journal.pone.0071248.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

Foley, J. F. "Detecting a Pathogenic Activity, Not a Pathogenic Molecule". Science Signaling 7, n.º 343 (16 de setembro de 2014): ec252-ec252. http://dx.doi.org/10.1126/scisignal.2005897.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Thongboonkerd, Visith, Wararat Chiangjong, Putita Saetun, Supachok Sinchaikul, Shui-Tein Chen e Uraiwan Kositanont. "Analysis of differential proteomes in pathogenic and non-pathogenic Leptospira : Potential pathogenic and virulence factors". PROTEOMICS 9, n.º 13 (julho de 2009): 3522–34. http://dx.doi.org/10.1002/pmic.200700855.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Bøe, Johs. "On the Distinction Between Pathogenic and Non-Pathogenic Staphylococci". Acta Pathologica Microbiologica Scandinavica 21, n.º 5 (14 de agosto de 2009): 721–30. http://dx.doi.org/10.1111/j.1699-0463.1944.tb04972.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Wurtzel, Omri, Nina Sesto, J. R. Mellin, Iris Karunker, Sarit Edelheit, Christophe Bécavin, Cristel Archambaud, Pascale Cossart e Rotem Sorek. "Comparative transcriptomics of pathogenic and non‐pathogenic Listeria species". Molecular Systems Biology 8, n.º 1 (janeiro de 2012): 583. http://dx.doi.org/10.1038/msb.2012.11.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

DiMiceli, Lauren. "Distinguishing Between Pathogenic and Non-Pathogenic Species of Entamoeba". Laboratory Medicine 35, n.º 10 (1 de outubro de 2004): 613–15. http://dx.doi.org/10.1309/b81npvaw8y4bgy11.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Roberts, Glenn D. "Medical Mycology: The Pathogenic Fungi and the Pathogenic Actinomycetes". Mayo Clinic Proceedings 63, n.º 10 (outubro de 1988): 1061–62. http://dx.doi.org/10.1016/s0025-6196(12)64931-3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Prasad, Rajendra, Frédéric Devaux, Sanjiveeni Dhamgaye e Dibyendu Banerjee. "Response of pathogenic and non-pathogenic yeasts to steroids". Journal of Steroid Biochemistry and Molecular Biology 129, n.º 1-2 (março de 2012): 61–69. http://dx.doi.org/10.1016/j.jsbmb.2010.11.011.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Hopsu-Havu, V. K., C. E. Sonck e Elvi Tunnela. "Production of Elastase by Pathogenic and Non-Pathogenic Fungi". Mycoses 15, n.º 3 (24 de abril de 2009): 105–10. http://dx.doi.org/10.1111/j.1439-0507.1972.tb01357.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Ahearn, Donald G. "Medical Mycology: The Pathogenic Fungi and the Pathogenic Actinomycetes". JAMA: The Journal of the American Medical Association 260, n.º 12 (23 de setembro de 1988): 1794. http://dx.doi.org/10.1001/jama.1988.03410120140051.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Gaminda, K. A. P. "DEOXYRIBOZYMES IN DETECTION OF PATHOGENIC BACTERIA". Biotechnologia Acta 14, n.º 5 (outubro de 2021): 5–20. http://dx.doi.org/10.15407/biotech14.05.005.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Resumo:

Aim. The purpose of the review was to analyze the use of DNAzyme biosensors for the detection of pathogens. In the recent years, deoxyribozymes (DNAzymes) have a significant impact as biosensors in diverse fields, from detection of metal ions in the environment to theranostic applications and detection of microorganisms. Although routinely used sophisticated instrumental methods are available to detect pathogenic bacterial contamination, they involve time-consuming, complicated sample pre-treatment and expensive instruments. As an alternative, pathogen-specific DNAzymes have demonstrated a series of advantages: a non-destructive rapid analysis technique with in situ and real-time detection of bacteria with high sensitivity and selectivity. A wide range of pathogen-specific DNAzymes has been developed using colorimetric and fluorescence-based detections for pathogenic bacterial contamination in various samples. The current review summarizes the in vitro selection of pathogen-specific DNAzymes, various strategies utilized in the sensor designs, and their potential use in theranostic applications.

24

Orlyankin, B. G., e T. I. Aliper. "Porcine pathogenic viruses". "Veterinary Medicine" Journal 23, n.º 01 (janeiro de 2020): 03–08. http://dx.doi.org/10.30896/0042-4846.2020.23.1.03-08.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Kaper, James B., James P. Nataro e Harry L. T. Mobley. "Pathogenic Escherichia coli". Nature Reviews Microbiology 2, n.º 2 (fevereiro de 2004): 123–40. http://dx.doi.org/10.1038/nrmicro818.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Parkhill, Julian, e Colin Berry. "Relative pathogenic values". Nature 423, n.º 6935 (maio de 2003): 23–24. http://dx.doi.org/10.1038/423023a.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Suerbaum, Sebastian, e Torkel Wadström. "Bacterial pathogenic factors". Current Opinion in Gastroenterology 11 (1995): 11–15. http://dx.doi.org/10.1097/00001574-199501001-00003.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Figura, Natale, e Soad Tabaqchali. "Bacterial pathogenic factors". Current Opinion in Gastroenterology 12 (janeiro de 1996): 11–15. http://dx.doi.org/10.1097/00001574-199601001-00003.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Bisel, Ryan S., e Debra J. Ford. "Diagnosing Pathogenic Eschatology". Communication Studies 59, n.º 4 (21 de novembro de 2008): 340–54. http://dx.doi.org/10.1080/10510970802467395.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Charlotte, Harrison. "Identifying pathogenic pathways". Nature Reviews Drug Discovery 12, n.º 7 (julho de 2013): 506. http://dx.doi.org/10.1038/nrd4061.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Barešić, Anja, e Andrew C. R. Martin. "Compensated pathogenic deviations". BioMolecular Concepts 2, n.º 4 (1 de agosto de 2011): 281–92. http://dx.doi.org/10.1515/bmc.2011.025.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Resumo:

AbstractDeleterious or ‘disease-associated’ mutations are mutations that lead to disease with high phenotype penetrance: they are inherited in a simple Mendelian manner, or, in the case of cancer, accumulate in somatic cells leading directly to disease. However, in some cases, the amino acid that is substituted resulting in disease is the wild-type native residue in the functionally equivalent protein in another species. Such examples are known as ‘compensated pathogenic deviations’ (CPDs) because, somewhere in the second species, there must be compensatory mutations that allow the protein to function normally despite having a residue which would cause disease in the first species. Depending on the nature of the mutations, compensation can occur in the same protein, or in a different protein with which it interacts. In principle, compensation can be achieved by a single mutation (most probably structurally close to the CPD), or by the cumulative effect of several mutations. Although it is clear that these effects occur in proteins, compensatory mutations are also important in RNA potentially having an impact on disease. As a much simpler molecule, RNA provides an interesting model for understanding mechanisms of compensatory effects, both by looking at naturally occurring RNA molecules and as a means of computational simulation. This review surveys the rather limited literature that has explored these effects. Understanding the nature of CPDs is important in understanding traversal along fitness landscape valleys in evolution. It could also have applications in treating diseases that result from such mutations.

32

Jauniaux, E. "I158 PATHOGENIC MECHANISMS". International Journal of Gynecology & Obstetrics 119 (outubro de 2012): S199—S200. http://dx.doi.org/10.1016/s0020-7292(12)60188-x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Angell, E. "Pathogenic waste treatment". Environment International 23, n.º 3 (1997): IX—X. http://dx.doi.org/10.1016/s0160-4120(97)88023-3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Kaper, James B. "Pathogenic Escherichia coli". International Journal of Medical Microbiology 295, n.º 6-7 (outubro de 2005): 355–56. http://dx.doi.org/10.1016/j.ijmm.2005.06.008.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Fattakhov, R. "Genesis pathogenic ecosystems". Parasitology International 47 (agosto de 1998): 329. http://dx.doi.org/10.1016/s1383-5769(98)80967-7.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Bahcall, Orli G. "Classifying pathogenic variation". Nature Reviews Genetics 16, n.º 3 (18 de fevereiro de 2015): 131. http://dx.doi.org/10.1038/nrg3915.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Holmes, Edward C. "Virology: Pathogenic passengers". Nature 478, n.º 7369 (outubro de 2011): 319–20. http://dx.doi.org/10.1038/478319a.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Shoenfeld, Yehuda. "Pathogenic natural autoantibodies". Clinical Immunology Newsletter 13, n.º 2-3 (fevereiro de 1993): 13–19. http://dx.doi.org/10.1016/0197-1859(93)90020-k.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Wackett, Lawrence P. "Plant pathogenic microorganisms". Environmental Microbiology 17, n.º 10 (outubro de 2015): 4143–44. http://dx.doi.org/10.1111/1462-2920.13067.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Kiberstis, P. A. "NEUROSCIENCE: Pathogenic Tangles". Science 287, n.º 5462 (31 de março de 2000): 2377f—2377. http://dx.doi.org/10.1126/science.287.5462.2377f.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Voelkner, Nadine. "Managing pathogenic circulation". Security Dialogue 42, n.º 3 (junho de 2011): 239–59. http://dx.doi.org/10.1177/0967010611405393.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Broder, Samuel. "Pathogenic Human Retroviruses". New England Journal of Medicine 318, n.º 4 (28 de janeiro de 1988): 243–45. http://dx.doi.org/10.1056/nejm198801283180409.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

H., G. C., e J. A. von Arx. "Plant Pathogenic Fungi". Mycologia 79, n.º 6 (novembro de 1987): 919. http://dx.doi.org/10.2307/3807701.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

van West, Pieter, e Gordon W. Beakes. "Animal pathogenic Oomycetes". Fungal Biology 118, n.º 7 (julho de 2014): 525–26. http://dx.doi.org/10.1016/j.funbio.2014.05.004.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Harborne, Jeffrey B. "Plant pathogenic bacteria". Phytochemistry 27, n.º 5 (janeiro de 1988): 1569–70. http://dx.doi.org/10.1016/0031-9422(88)80251-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Calam, John. "4 Pathogenic mechanisms". Baillière's Clinical Gastroenterology 9, n.º 3 (setembro de 1995): 487–506. http://dx.doi.org/10.1016/0950-3528(95)90044-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Solbrig, Marylou V. "Human pathogenic arenaviruses". Annals of Neurology 64, n.º 3 (25 de fevereiro de 2008): 355–56. http://dx.doi.org/10.1002/ana.21350.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Filip, Z., D. Kaddu-Mulindwa e G. Milde. "Survival of Some Pathogenic and Facultative Pathogenic Bacteria in Groundwater". Water Science and Technology 20, n.º 3 (1 de março de 1988): 227–31. http://dx.doi.org/10.2166/wst.1988.0105.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Resumo:

In model experiments carried out in the laboratory the survival of bacteria in groundwater kept at 10±l °C was tested. Only two of the tested bacteria species did not survive longer than 10 - 30 days. Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa and other pathogenic or facultative pathogenic bacteria survived up to 100 days or even more in ground-water with or without the addition of sand from an aquifer. These results can be of importance for determining groundwater protection zones.

49

Napalkova, G. M., I. I. Korsakova, N. P. Khrapova, N. N. Piven', L. V. Lomova e T. V. Bulatova. "Differentiation of Pathogenic and Non-Pathogenic Burkholderias Using Rocket Immunoelectrophoresis". Problems of Particularly Dangerous Infections, n.º 4(106) (20 de agosto de 2010): 37–38. http://dx.doi.org/10.21055/0370-1069-2010-4(106)-37-38.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Resumo:

Demostrated is the possibility to differentiate virulent strains of melioidosis and glanders etiological agents from avirulent ones and closely related microorganisms according to the presence of the antigenic complex 8, using rocket immunoelectrophoresis with the serum containing antibodies to this complex.

50

Korva, Miša, Nataša Knap, Katarina Rus, Luka Fajs, Gašper Grubelnik, Matejka Bremec, Tea Knapič, Tomi Trilar e Tatjana Županc. "Phylogeographic Diversity of Pathogenic and Non-Pathogenic Hantaviruses in Slovenia". Viruses 5, n.º 12 (10 de dezembro de 2013): 3071–87. http://dx.doi.org/10.3390/v5123071.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.